SOHO Italy 2022: Phase 3 SELECT-MDS-1 Study - A Randomized, Double-Blind, Placebo-Controlled Study of Tamibarotene + Aza vs. Placebo + Aza in Newly Diagnosed Adult Patients Selected for RARA+ HR-MDS